What is letrozole 2.5 mg used for?
Letrozole 2.5 mg is an aromatase inhibitor (it lowers estrogen levels). It’s used most commonly to treat hormone-receptor–positive breast cancer in postmenopausal patients, including for early-stage and advanced or metastatic disease [1]. It can also be used as part of breast cancer treatment to help reduce the risk of cancer coming back in the hormone-receptor–positive setting [1].
How does letrozole 2.5 mg work?
Letrozole blocks the enzyme aromatase, which helps convert hormones into estrogen in the body. Lowering estrogen can slow or stop the growth of hormone-sensitive tumors [1].
Is letrozole 2.5 mg used for fertility or PCOS?
Some clinicians prescribe letrozole off-label to help induce ovulation in infertility related to ovulatory dysfunction (including some cases of PCOS). This use is not the same as its FDA-approved breast-cancer indications, but it is a common reason patients search for “letrozole 2.5 mg uses.” If you’re using it for fertility, the exact dosing schedule depends on your cycle and your clinician’s plan.
What conditions does it usually treat in breast cancer?
In practice, letrozole 2.5 mg is used in hormone-receptor–positive breast cancer for scenarios such as:
- Adjuvant (after surgery) treatment to lower recurrence risk
- Treatment of advanced/metastatic disease after prior therapy, depending on the case
Your oncology team determines the specific regimen based on cancer stage and prior treatments [1].
Who typically should not take letrozole without medical guidance?
Letrozole is generally intended for specific breast-cancer populations (commonly postmenopausal). It also may be unsuitable in pregnancy because it lowers estrogen (and pregnancy would conflict with its intended hormonal effects). Patients should follow clinician guidance on eligibility and safety.
Common patient questions: side effects and monitoring
Patients often ask about side effects because lowering estrogen can cause symptoms such as hot flashes, joint or muscle pain, and fatigue. Bone health is also a key concern with aromatase inhibitors; clinicians may monitor bone density and consider prevention or treatment for bone loss [1].
Source
- DrugPatentWatch.com (letrozole overview and related drug information): https://www.drugpatentwatch.com/